Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): Results of a pilot study

Journal of Perinatal Medicine

Volumn 36, Issue 5, 2008, Pages 399-404

  Hájek, Zdeněk ^a   Germanová, Anna ^a   Koucký, Michal ^a   Zima, Tomáš ^a   Kopecký, Pavel ^a   Vítkova, Marie ^a   Pařízek, Antonín ^a   Kalousová, Marta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Fetal inflammation; PPROM; Preterm labor; Soluble receptor for advanced glycation end products; SRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; PILOT STUDY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INTERLEUKIN-6; OBSTETRIC LABOR, PREMATURE; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTORS, IMMUNOLOGIC;

EID: 51549097596     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2008.080     Document Type: Article

References (26)

1. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, et al. sRAGE is elevated in septic patients and associated with patient outcome. J Surg Res. 2008;147:79-83.
2. Buhimschi CS, Sfakianaki K, Hamar BG, Pettker CM, Bahtyiar MO, Funai E, et al. A low vaginal "pool" amniotic fluid glucose measurement is a predictive but not a sensitive marker for infection in women with preterm premature rupture of membranes. Am J Obstet Gynecol. 2006;194:309-16.
3. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol. 2007;196:1811-3.
4. Chekir C, Nakatsuka M, Noguchi S, Konushi H, Kamada Y, Sasaki A, et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitritive stress. Placenta. 2006;27:225-33.
5. Cooke CL, Brockelsby JC, Baker Davidge ST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy. 2003;22:173-84.
6. Falcone C, Campo I, Emanuele E, Buzzi MP, Geroldi D, Belvito C, et al. 374 T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clin Chim Acta. 2005;354:111-6.
7. Fialova L, Malbohan I, Kalousova M, Soukupova J, Krofta L, Stipek S, et al. Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest. 2006;66:121-7.
8. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Gene Immun. 2002;3:117-8.
9. Hudson BI, Harja E, Moser B, Schmidt AM. Soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein? Arterioscler Thromb Vasc Biol. 2005;25:879-82.
10. Hudson BI, Schmidt AM. RAGE a novel target for drug intervention in diabetic vascular disease Pharm Res. 2004;21:1079-86.
11. Kalousova M, Bartosova K, Zima T, Skibova J, Teplan J, Viklicky O. Pregnancy associated plasma protein A and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res. 2007;30:31-7.
12. Kalousova M, Hodkova M, Kazderova M, Fialova J, Tesař V, Dusilova-Sulkova S, et al. Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis. 2006;47:406-11.
13. Kalousova M, Jachymova M, Mestek O, Hodkova M, Kazderova M, Tesar V, et al. Receptor for advanced glycation end products - soluble form and gene polymorphism in chronic haemodialysis patients. Nephrol Dial Transplant. 2007;22:2020-6.
14. Lewis DF, Robichaux AG, Jaekle RK, Salas A, Canzoneri BJ, Horton K, et al. Expectant management of preterm premature rupture of membranes and nonvertex presentation: what are the risks? Am J Obstet Gynecol. 2007;196:566.e1-e6.
15. Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, Agardh E, Groop L, et al. The 374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy in type 1 diabetic patients. Diabetologia. 2006;49:2745-55.
16. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. Decreased level of soluble receptor for advanced glycation end products in patients with reumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ter. 2005;7:142-4.
17. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Sem Repr Med. 2007;25:21-32.
18. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. Br J Obstet Gynaecol. 2006;113(Suppl. 3):17-42.
19. Schmidt AM, Hori O, Chen JX. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395-403.
20. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta. 2000;1498:99-111.
21. Torbé A. Maternal plasma procalcitonin concentration in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007;2007:35782.
22. Torbé A, Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinical infection in patients with preterm premature rupture of membranes? J Obstet Gynaecol Res. 2005;31:464-70.
23. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systemic review. Br J Obstet Gynaecol. 2007;114:796-801.
24. Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, et al. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advanced glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum. 2007;56:4174-81.
25. Yang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, et al. Association of Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic nonobese Koreans. Metabolism. 2007;56:199-205.
26. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation end products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 2003;370:1097-109.